1.Comparison of surgical outcomes of intracorporeal hepaticojejunostomy in the excision of choledochal cysts using laparoscopic versus robot techniques.
Hongeun LEE ; Wooil KWON ; Youngmin HAN ; Jae Ri KIM ; Sun Whe KIM ; Jin Young JANG
Annals of Surgical Treatment and Research 2018;94(4):190-195
PURPOSE: Increasing surgical expertise in minimally invasive surgery has allowed laparoscopic surgery to be performed in many abdominal surgeries. Laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy are challenging and sophisticated surgeries because of the difficult anastomosis. Recent advances in robotic surgery have enabled more delicate and precise movements, and Endowrist instruments allow for securing sutures during anastomosis. This study aimed to compare surgical outcomes of laparoscopic and robotic hepaticojejunostomy in choledochal cyst excision. METHODS: Sixty-seven patients who underwent laparoscopic or robotic-hybrid choledochal cyst excision from 2004 to 2016 were retrospectively analyzed and compared. In robotic surgery, dissection was performed laparoscopically, and hepaticojejunostomy was performed using a robotic platform. RESULTS: The mean operative time was significantly longer in robotic surgery than in laparoscopic surgery (247.94 ± 54.14 minutes vs. 181.31 ± 43.06 minutes, P < 0.05). The mean estimated blood loss (108.71 ± 15.53 mL vs. 172.78 ± 117.46 mL, respectively, P = 0.097) and postoperative hospital stay (7.33 ± 2.96 days vs. 6.22 ± 1.06 days, P = 0.128) were comparable between procedures. Compared to the laparoscopic approaches, robotic surgery had significantly less short-term complications (22.4% vs. 0%, P = 0.029). There were more biliary leakage (n = 7, 14.3%) observed during the first 30 days after surgery in laparoscopy while none were observed in the robotic method. CONCLUSION: Robotic surgery allow for more precise and secure sutures during anastomosis thereby reducing biliary complications. With expanding knowledge and expertise, robotic surgery may offer more advantages over laparoscopy in the era of minimally invasive surgery.
Anastomosis, Roux-en-Y
;
Choledochal Cyst*
;
Humans
;
Laparoscopy
;
Length of Stay
;
Methods
;
Minimally Invasive Surgical Procedures
;
Operative Time
;
Retrospective Studies
;
Robotic Surgical Procedures
;
Sutures
2.False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients.
Hongeun LEE ; Jeong Hee YOON ; Hyeyoung KIM ; Nam Joon YI ; Suk Kyun HONG ; Kyung Chul YOON ; Hyo Sin KIM ; Sung Woo AHN ; Jin Young CHOI ; YoungRok CHOI ; Hae Won LEE ; Ju Yeon YI ; Kyoung Bun LEE ; Kwang Woong LEE ; Kyung Suk SUH
Journal of Korean Medical Science 2017;32(2):315-320
The diagnosis of hepatocellular carcinoma (HCC) is based on imaging studies particularly in high-risk patients without histologic confirmation. This study evaluated the prevalence and characteristics of false-positively diagnosed HCC in a liver resection cohort for HCC. A retrospective review was performed of 837 liver resection cases for clinically diagnosed HCC between 2005 and 2010 at our institute. High-risk patients with tumors > 1 cm with one or two image findings consistent with HCC and tumors < 1 cm with two or more image findings consistent with HCC with persistently increased serum alpha-fetoprotein (AFP) levels above the normal range with underlying inhibited hepatitis activity underwent liver resection. The false-positive rate was 2.2% (n = 18). Of the 18 patients, 7 patients (0.8%) were diagnosed with benign conditions (one each of hemangioma, inflammation, cortical adenoma, dysplastic nodule, angiomyolipoma, bile duct adenoma, and non-neoplastic liver parenchyme) and 11 patients (1.3%) were diagnosed with malignancies (cholangiocarcinoma [n = 6], hepatoblastoma [n = 2], and one each of lymphoepithelioma-like carcinoma, ovarian cystadenocarcinoma, and nasopharynx carcinoma metastasis). The clinical characteristics of pathologically diagnosed HCC patients were similar (P > 0.05) compared to non-HCC patients except for higher rate of history of alcoholism (P < 0.05) observed in non-HCC patients. Four of 18 non-HCC patients (22.2%) showed diagnostic discordance on the dynamic imaging study. Despite the recent progression in diagnostic imaging techniques, 2.2% of cases were false-positively diagnosed as HCC in a liver resection patient cohort; and the final diagnosis was benign disease in 0.8% of liver resection patients clinically diagnosed with HCC.
Adenoma
;
Adenoma, Bile Duct
;
Alcoholism
;
alpha-Fetoproteins
;
Angiomyolipoma
;
Carcinoma, Hepatocellular*
;
Cohort Studies
;
Cystadenocarcinoma
;
Diagnosis*
;
Diagnostic Imaging
;
Hemangioma
;
Hepatitis
;
Hepatoblastoma
;
Humans
;
Inflammation
;
Liver*
;
Nasopharynx
;
Prevalence
;
Reference Values
;
Retrospective Studies